Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|November 7, 2023
Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACsRebecca Stevens, Enrique Bendito-Moll, David J Battersby, et al.
Annals of Surgery|March 31, 2015
Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II StudyNicholas J Battersby, Peter How, Brendan Moran, et al.
Genetics|March 27, 2015
Quantitative changes in Gimap3 and Gimap5 expression modify mitochondrial DNA segregation in miceRiikka Jokinen, Taina Lahtinen, Paula Marttinen, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Structure determination and dual targeting of a plant TACO1 identifies its ancient role as an organelle translation regulatorParth K Raval, Nuša Kos Thaler, Cristopher Mitchell, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 26, 2013
The English national low rectal cancer development programme: key messages and future perspectivesB J Moran, T Holm, G Brannagan, et al.
Iscience|July 17, 2024
Supernumerary proteins of the human mitochondrial ribosomal small subunit are integral for assembly and translationTaru Hilander, Ryan Awadhpersad, Geoffray Monteuuis, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trialIfedayo M Adetifa, Martin O C Ota, David J Jeffries, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Intrinsic errors in mitochondrial translation trigger a decline in cell fitnessGüleycan Lutfullahoglu Bal, Kah Ying Ng, Eli Berzell, et al.
Life Science Alliance|January 27, 2019
Mitochondrial stress response triggered by defects in protein synthesis quality controlUwe Richter, Kah Ying Ng, Fumi Suomi, et al.
Trials|August 31, 2017
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trialNick J Battersby, Mit Dattani, Sheela Rao, et al.
Pageof 10